149 related articles for article (PubMed ID: 14600569)
41. Diverse repertoire of HIV-1 p24-specific, IFN-gamma-producing CD4+ T cell clones following immune reconstitution on highly active antiretroviral therapy.
Boritz E; Palmer BE; Livingston B; Sette A; Wilson CC
J Immunol; 2003 Jan; 170(2):1106-16. PubMed ID: 12517980
[TBL] [Abstract][Full Text] [Related]
42. Discordance between frequency of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon-producing CD4(+) T cells and HIV-1-specific lymphoproliferation in HIV-1-infected subjects with active viral replication.
Palmer BE; Boritz E; Blyveis N; Wilson CC
J Virol; 2002 Jun; 76(12):5925-36. PubMed ID: 12021325
[TBL] [Abstract][Full Text] [Related]
43. An HLA-directed molecular and bioinformatics approach identifies new HLA-A11 HIV-1 subtype E cytotoxic T lymphocyte epitopes in HIV-1-infected Thais.
Bond KB; Sriwanthana B; Hodge TW; De Groot AS; Mastro TD; Young NL; Promadej N; Altman JD; Limpakarnjanarat K; McNicholl JM
AIDS Res Hum Retroviruses; 2001 May; 17(8):703-17. PubMed ID: 11429111
[TBL] [Abstract][Full Text] [Related]
44. CD8+ T cell responses to human immunodeficiency viruses type 2 (HIV-2) and type 1 (HIV-1) gag proteins are distinguishable by magnitude and breadth but not cellular phenotype.
Gillespie GM; Pinheiro S; Sayeid-Al-Jamee M; Alabi A; Kaye S; Sabally S; Sarge-Njie R; Njai H; Joof K; Jaye A; Whittle H; Rowland-Jones S; Dorrell L
Eur J Immunol; 2005 May; 35(5):1445-53. PubMed ID: 15832290
[TBL] [Abstract][Full Text] [Related]
45. Phenotypic, functional, and kinetic parameters associated with apparent T-cell control of human immunodeficiency virus replication in individuals with and without antiretroviral treatment.
Emu B; Sinclair E; Favre D; Moretto WJ; Hsue P; Hoh R; Martin JN; Nixon DF; McCune JM; Deeks SG
J Virol; 2005 Nov; 79(22):14169-78. PubMed ID: 16254352
[TBL] [Abstract][Full Text] [Related]
46. The frequency of HIV-specific interferon- gamma -producing CD8 T cells is associated with both age and level of antigenic stimulation in HIV-1-infected children.
Buseyne F; Scott-Algara D; Bellal N; Burgard M; Rouzioux C; Blanche S; Riviere Y
J Infect Dis; 2005 Nov; 192(10):1781-6. PubMed ID: 16235177
[TBL] [Abstract][Full Text] [Related]
47. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA.
Ogg GS; Jin X; Bonhoeffer S; Dunbar PR; Nowak MA; Monard S; Segal JP; Cao Y; Rowland-Jones SL; Cerundolo V; Hurley A; Markowitz M; Ho DD; Nixon DF; McMichael AJ
Science; 1998 Mar; 279(5359):2103-6. PubMed ID: 9516110
[TBL] [Abstract][Full Text] [Related]
48. Viral replication capacity as a correlate of HLA B57/B5801-associated nonprogressive HIV-1 infection.
Navis M; Schellens I; van Baarle D; Borghans J; van Swieten P; Miedema F; Kootstra N; Schuitemaker H
J Immunol; 2007 Sep; 179(5):3133-43. PubMed ID: 17709528
[TBL] [Abstract][Full Text] [Related]
49. Proliferation responses to HIVp24 during antiretroviral therapy do not reflect improved immune phenotype or function.
Lange CG; Xu Z; Patterson BK; Medvik K; Harnisch B; Asaad R; Valdez H; Lee SJ; Landay A; Lieberman J; Lederman MM
AIDS; 2004 Mar; 18(4):605-13. PubMed ID: 15090765
[TBL] [Abstract][Full Text] [Related]
50. New CD4+ and CD8+ T cell responses induced in chronically HIV type-1-infected patients after immunizations with an HIV type 1 lipopeptide vaccine.
Gahery H; Daniel N; Charmeteau B; Ourth L; Jackson A; Andrieu M; Choppin J; Salmon D; Pialoux G; Guillet JG
AIDS Res Hum Retroviruses; 2006 Jul; 22(7):684-94. PubMed ID: 16831093
[TBL] [Abstract][Full Text] [Related]
51. Decay kinetics of human immunodeficiency virus-specific CD8+ T cells in peripheral blood after initiation of highly active antiretroviral therapy.
Casazza JP; Betts MR; Picker LJ; Koup RA
J Virol; 2001 Jul; 75(14):6508-16. PubMed ID: 11413318
[TBL] [Abstract][Full Text] [Related]
52. Cytolytic T lymphocytes (CTLs) from HIV-1 subtype C-infected Indian patients recognize CTL epitopes from a conserved immunodominant region of HIV-1 Gag and Nef.
Thakar MR; Bhonge LS; Lakhashe SK; Shankarkumar U; Sane SS; Kulkarni SS; Mahajan BA; Paranjape RS
J Infect Dis; 2005 Sep; 192(5):749-59. PubMed ID: 16088824
[TBL] [Abstract][Full Text] [Related]
53. Large HIV-specific CD8 cytotoxic T-lymphocyte (CTL) clones reduce their overall size but maintain high frequencies of memory CTL following highly active antiretroviral therapy.
Weekes MP; Wills MR; Sissons JG; Carmichael AJ
Immunology; 2006 May; 118(1):25-38. PubMed ID: 16630020
[TBL] [Abstract][Full Text] [Related]
54. Human immunodeficiency virus type I-specific CD8+ T cell subset abnormalities in chronic infection persist through effective antiretroviral therapy.
Pohling J; Zipperlen K; Hollett NA; Gallant ME; Grant MD
BMC Infect Dis; 2010 May; 10():129. PubMed ID: 20500844
[TBL] [Abstract][Full Text] [Related]
55. Programmed death 1 expression on HIV-specific CD4+ T cells is driven by viral replication and associated with T cell dysfunction.
D'Souza M; Fontenot AP; Mack DG; Lozupone C; Dillon S; Meditz A; Wilson CC; Connick E; Palmer BE
J Immunol; 2007 Aug; 179(3):1979-87. PubMed ID: 17641065
[TBL] [Abstract][Full Text] [Related]
56. Impairment of Gag-specific CD8(+) T-cell function in mucosal and systemic compartments of simian immunodeficiency virus mac251- and simian-human immunodeficiency virus KU2-infected macaques.
Hel Z; Nacsa J; Kelsall B; Tsai WP; Letvin N; Parks RW; Tryniszewska E; Picker L; Lewis MG; Edghill-Smith Y; Moniuszko M; Pal R; Stevceva L; Altman JD; Allen TM; Watkins D; Torres JV; Berzofsky JA; Belyakov IM; Strober W; Franchini G
J Virol; 2001 Dec; 75(23):11483-95. PubMed ID: 11689630
[TBL] [Abstract][Full Text] [Related]
57. The CD160+ CD8high cytotoxic T cell subset correlates with response to HAART in HIV-1+ patients.
Nikolova MH; Muhtarova MN; Taskov HB; Kostov K; Vezenkov L; Mihova A; Boumsell L; Bensussan A
Cell Immunol; 2005 Oct; 237(2):96-105. PubMed ID: 16337931
[TBL] [Abstract][Full Text] [Related]
58. Multifunctional human immunodeficiency virus (HIV) gag-specific CD8+ T-cell responses in rectal mucosa and peripheral blood mononuclear cells during chronic HIV type 1 infection.
Critchfield JW; Lemongello D; Walker DH; Garcia JC; Asmuth DM; Pollard RB; Shacklett BL
J Virol; 2007 Jun; 81(11):5460-71. PubMed ID: 17344302
[TBL] [Abstract][Full Text] [Related]
59. Strong human immunodeficiency virus (HIV)-specific CD4+ T cell responses in a cohort of chronically infected patients are associated with interruptions in anti-HIV chemotherapy.
Haslett PA; Nixon DF; Shen Z; Larsson M; Cox WI; Manandhar R; Donahoe SM; Kaplan G
J Infect Dis; 2000 Apr; 181(4):1264-72. PubMed ID: 10751137
[TBL] [Abstract][Full Text] [Related]
60. HIV-specific cytotoxic T-lymphocyte activity in immunologically normal HIV-infected persons.
Bernard NF; Pederson K; Chung F; Ouellet L; Wainberg MA; Tsoukas CM
AIDS; 1998 Nov; 12(16):2125-39. PubMed ID: 9833853
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
